Timmermann, S., & Hall, A. (2019). Population pharmacokinetics of brodalumab in patients with moderate to severe plaque psoriasis. Basic Clin Pharmacol Toxicol.
Chicago Style CitationTimmermann, Stine, i Anders Hall. "Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis." Basic Clin Pharmacol Toxicol 2019.
Cita MLATimmermann, Stine, i Anders Hall. "Population Pharmacokinetics of Brodalumab in Patients With Moderate to Severe Plaque Psoriasis." Basic Clin Pharmacol Toxicol 2019.
Atenció: Aquestes cites poden no estar 100% correctes.